Effect of Routine Invasive vs Conservative Strategy in Older Adults With Frailty and Non–ST-Segment Elevation Acute Myocardial Infarction
JAMA Internal Medicine · 01.05.2023 · 183 (5) · 407
DOI: 10.1001/jamainternmed.2023.0047 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Internal Medicine, erschienen am 01.05.2023. Verfasst von Juan Sanchis und 24 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, University Clinic Hospital of València, University of València, INCLIVA, CIBERCV, València, Spain. Hauptthemen laut MEDLINE: Non-ST Elevated Myocardial Infarction, Myocardial Infarction, Frailty, COVID-19. Die Arbeit wurde bisher 122-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Importance To our knowledge, no randomized clinical trial has compared the invasive and conservative strategies in frail, older patients with non–ST-segment elevation acute myocardial infarction (NSTEMI).
Objective
To compare outcomes of invasive and conservative strategies in frail, older patients with NSTEMI at 1 year. Design, Setting, and Participants This multicenter randomized clinical trial was conducted at 13 Spanish hospitals between July 7, 2017, and January 9, 2021, and included 167 older adult (≥70 years) patients with frailty (Clinical Frailty Scale score ≥4) and NSTEMI. Data analysis was performed from April 2022 to June 2022.
Interventions
Patients were randomized to routine invasive (coronary angiography and revascularization if feasible; n = 84) or conservative (medical treatment with coronary angiography for recurrent ischemia; n = 83) strategy. Main Outcomes and Measures The primary end point was the number of days alive and out of the hospital (DAOH) from discharge to 1 year. The coprimary end point was the composite of cardiac death, reinfarction, or postdischarge revascularization.
Results
The study was prematurely stopped due to the COVID-19 pandemic when 95% of the calculated sample size had been enrolled. Among the 167 patients included, the mean (SD) age was 86 (5) years, and mean (SD) Clinical Frailty Scale score was 5 (1). While not statistically different, DAOH were about 1 month (28 days; 95% CI, −7 to 62) greater for patients managed conservatively (312 days; 95% CI, 289 to 335) vs patients managed invasively (284 days; 95% CI, 255 to 311; P = .12). A sensitivity analysis stratified by sex did not show differences. In addition, we found no differences in all-cause mortality (hazard ratio, 1.45; 95% CI, 0.74-2.85; P = .28). There was a 28-day shorter survival in the invasive vs conservatively managed group (95% CI, −63 to 7 days; restricted mean survival time analysis). Noncardiac reasons accounted for 56% of the readmissions. There were no differences in the number of readmissions or days spent in the hospital after discharge between groups. Neither were there differences in the coprimary end point of ischemic cardiac events (subdistribution hazard ratio, 0.92; 95% CI, 0.54-1.57; P = .78). Conclusions and Relevance In this randomized clinical trial of NSTEMI in frail older patients, there was no benefit to a routine invasive strategy in DAOH during the first year. Based on these findings, a policy of medical management and watchful observation is recommended for older patients with frailty and NSTEMI. Trial Registration ClinicalTrials.gov Identifier: NCT03208153
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Cardiology Department, University Clinic Hospital of València, University of València, INCLIVA, CIBERCV, València, Spain.
- Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain, Cardiology Department, Universisty Hospital 12 de Octubre and Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, CIBE…
- Cardiology Department, University Hospital of Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
- Central Defense Hospital, Madrid, Alcalá University, Madrid, Spain.
- Cardiology Department, University Hospital Gregorio Marañón, CIBERCV, Complutense University, European University, Madrid, Spain.
- University Hospital La Princesa, Autonomous University of Madrid, IIS-IP, CIBERCV Madrid, Spain.
Zitieren
APA
Sanchis, J., Bueno, H., Miñana, G., Guerrero, C., Martí, D., Martínez-Sellés, M., Domínguez-Pérez, L., Díez-Villanueva, P., Barrabés, J. A., Marín, F., Villa, A., Sanmartín, M., Llibre, C., Sionís, A., Carol, A., García-Blas, S., Calvo, E., Morales Gallardo, M. J., Elízaga, J., …, & Ariza-Solé, A. (2023). Effect of Routine Invasive vs Conservative Strategy in Older Adults With Frailty and Non–ST-Segment Elevation Acute Myocardial Infarction. JAMA Internal Medicine, 183(5), 407. https://doi.org/10.1001/jamainternmed.2023.0047
Vancouver
Sanchis J, Bueno H, Miñana G, Guerrero C, Martí D, Martínez-Sellés M, et al. Effect of Routine Invasive vs Conservative Strategy in Older Adults With Frailty and Non–ST-Segment Elevation Acute Myocardial Infarction. JAMA Internal Medicine. 2023;183(5):407. doi:10.1001/jamainternmed.2023.0047
BibTeX
@article{Sanchis2023,
author = {Sanchis, Juan and Bueno, Héctor and Miñana, Gema and Guerrero, Carme and Martí, David and Martínez-Sellés, Manuel and Domínguez-Pérez, Laura and Díez-Villanueva, Pablo and Barrabés, Jose A and Marín, Francisco and Villa, Adolfo and Sanmartín, Marcelo and Llibre, Cinta and Sionís, Alessandro and Carol, Antoni and García-Blas, Sergio and Calvo, Elena and Morales Gallardo, María José and Elízaga, Jaime and Gómez-Blázquez, Iván and Alfonso, Fernando and García Del Blanco, Bruno and Núñez, Julio and Formiga, Francesc and Ariza-Solé, Albert},
title = {Effect of Routine Invasive vs Conservative Strategy in Older Adults With Frailty and Non–ST-Segment Elevation Acute Myocardial Infarction},
journal = {JAMA Internal Medicine},
year = {2023},
volume = {183},
number = {5},
pages = {407},
doi = {10.1001/jamainternmed.2023.0047}
}
EUVIMED